Maccura Biotechnology Co.Ltd(300463)
Announcement on the appointment of senior managers and securities affairs representatives
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Maccura Biotechnology Co.Ltd(300463) (hereinafter referred to as “the company”) held the first meeting of the Fifth Board of directors on January 17, 2022, deliberated and adopted the proposal on the appointment of senior managers and securities affairs representatives of the company, and now the relevant information is announced as follows:
The board of directors of the company agrees to reappoint Mr. Wu Mingjian as the general manager of the company; Mr. Xu Shengguo was reappointed as the director of market operation, Mr. long TengXiang as the director of R & D (Reagent), Mr. Wang Weijia as the director of R & D (instrument), Ms. Yang Hui as the director of production (Reagent), Mr. Wang Zhen as the director of production (instrument), Mr. Li Bo as the director of business, Ms. Yin Shan as the chief financial officer and Ms. Yu Ping as the chief administrative officer; Renew the appointment of Ms. Shi Wei as director of strategic investment and Secretary of the board of directors; Renew the appointment of Ms. Zhang Wenjun as securities representative. The term of office of the above-mentioned senior managers and securities affairs representatives is from the date of deliberation and approval at the first meeting of the Fifth Board of directors to the date of expiration of the Fifth Board of directors (see Annex for resume).
The above-mentioned personnel have the qualifications suitable for the exercise of their functions and powers, and there is no situation that they are not allowed to serve as senior managers, Secretary of the board of directors and securities affairs representative of the company as stipulated in the company law, Shenzhen Stock Exchange GEM Listing Rules and the articles of association, nor are they determined by the CSRC to be prohibited from entering the market and in the period of prohibition, He has not received the punishment of the CSRC and other relevant departments or the punishment of the stock exchange, and is not the person subjected to execution for breaking his promise; The qualification is legal, and the appointment procedure is legal and compliant. The independent directors of the company expressed their independent opinions on the appointment of senior managers.
Ms. Shi Wei and Ms. Zhang Wenjun have obtained the qualification certificate of secretary of the board of directors issued by Shenzhen Stock Exchange, and their qualifications comply with relevant provisions such as Shenzhen Stock Exchange gem stock listing rules, Shenzhen Stock Exchange listed companies self regulatory guidelines No. 2 – Guidelines for standardized operation of companies listed on GEM and the articles of association.
The contact information of the Secretary of the board of directors and the securities affairs representative is as follows:
Contact: Shi Wei, Zhang Wenjun
Contact address: No. 8, Anhe 2nd Road, high tech Zone, Chengdu, Sichuan
Tel.: 028-81731186
Fax: 028-81731188
mail box: [email protected].
It is hereby announced.
Attachment: resumes of senior managers and securities affairs representatives
Attachment of the board of directors on January 18, 2002: resumes of senior managers and securities affairs representatives
Mr. Wu Mingjian, born in December 1975, Chinese nationality, without permanent residency abroad, master’s degree, senior accountant. He once worked in Sichuan Guoli Network Technology Co., Ltd. and Chengdu classic Information Technology Co., Ltd. of Guangdong Guoli group. He has worked in Mike technology company since 2002. He once served as the company’s financial manager, commercial director and strategic investment director. He is now the company’s director and general manager. As of the date of this announcement, Mr. Wu Mingjian holds 1104642 shares of the company. In addition, he is not related to other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Mr. Xu Shengguo, born in November 1978, Chinese nationality, without permanent residency abroad, has a master’s degree. He has worked in Mike technology since 2001 and is now the director and director of market operation of the company.
As of the date of this announcement, Mr. Xu Shengguo holds 162919 shares of the company. In addition, he is not related to other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Mr. long TengXiang, born in August 1981, Chinese nationality, without permanent residency abroad, has a master’s degree. Graduated from biochemistry and molecular biology, School of laboratory medicine, Chongqing Medical University, worked in the company since 2005, once served as the chief engineer of the company’s reagent production system, and now serves as the company’s R & D Director (Reagent). Mr. long TengXiang is now a member of the National Technical Committee for standardization of medical clinical laboratory and in vitro diagnostic system (SAC / tc136), the National Technical Committee for standardization of biochemical testing (SAC / tc387), the professional committee of labeling immunoassay of China Association for analysis and testing, the standardization group of laboratory medicine sub group of China Medical Equipment Association Member of luminous standardization and application group of laboratory medicine branch of China Medical Equipment Association, member of Teaching Steering Committee of medical technology specialty of Sichuan ordinary undergraduate colleges and universities (2021-2025), and risk assessment expert of Sichuan entry-exit special goods.
Up to now, Mr. long TengXiang holds 75459 shares of the company. In addition, he is not related to other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Mr. Wang Weijia, born in November 1983, Chinese nationality, without permanent residency abroad, has a master’s degree. Graduated from biomedical engineering of Southwest Jiaotong University, worked in the company since 2010, once served as the manager of Maccura Biotechnology Co.Ltd(300463) R & D department, and now serves as the director (instrument) of Maccura Biotechnology Co.Ltd(300463) .
Up to now, Mr. Wang Weijia holds 67913 shares of the company. In addition, he is not related to other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Ms. Yang Hui, born in March 1967, Chinese nationality, without permanent residency abroad, with a bachelor’s degree. He graduated from Chongqing Medical University in 1990, majored in medical laboratory, and once worked in the laboratory department of China Metallurgical hospital. He has worked in the company since 2001. He once served as the workshop director of the production department, the manager of the production management department, the chief engineer of the reagent production system and the shareholder supervisor of the company. He is now the general production supervisor (Reagent) of the company.
Up to now, Ms. Yang Hui holds 2745500 shares of the company. In addition, she is not related to other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Mr. Wang Zhen, born in April 1970, Chinese nationality, without permanent residency abroad, has a master’s degree. He once worked in Sichuan Jianyang food company, Shenzhen Far East Hotel and Wenyuan restaurant of Zhonghua Book Company on Wangfujing Group Co.Ltd(600859) street in Beijing. He has worked in the company since 2000 and is now the production director (instrument) of the company.
Up to now, Mr. Wang Zhen holds 48875 shares of the company. In addition, he is not related to other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Mr. Li Bo, born in January 1977, Chinese nationality, without permanent residency abroad, has a master’s degree. He graduated from the medical laboratory specialty of Chengdu Medical College in 2001 and obtained the master of Business Administration (EMBA) degree of senior managers of Southwest University of Finance and economics in 2016. He has worked in the company since 2001 and is now the business director of the company.
As of the date of this announcement, Mr. Li Bo does not hold shares of the company and has no relationship with the controlling shareholder, actual controller, other shareholders holding more than 5% shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Ms. Yin Shan, born in June 1980, Chinese nationality, without permanent residency abroad, has a master’s degree. Graduated from Sichuan Institute of technology in 2002, majored in financial management, and obtained the national master of Business Administration (MBA) from Southwest Jiaotong University in 2018. He has worked in the company since 2004, once served as the financial director and financial manager of Maccura Biotechnology Co.Ltd(300463) financial management department, and now serves as the financial director of Maccura Biotechnology Co.Ltd(300463) .
Up to now, Ms. Yin Shan holds 39930 shares of the company. In addition, she has no relationship with other shareholders holding more than 5% of the company’s shares, as well as other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Ms. Yu Ping, born in 1979, Chinese nationality, without permanent residency abroad, has a master’s degree. He once served as the company’s administrative director, deputy manager of human resources department and manager of human resources department. Now he is the company’s administrative director and manager of human resources department.
Up to now, Ms. Yu Ping holds 65166 shares of the company. In addition, she is not related to other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Ms. Shi Wei, born in 1974, Chinese nationality, without permanent residency abroad, bachelor degree, intermediate accountant. He once worked in Xi’an Railway Branch of the Ministry of Railways of China. He has worked in the company since March 2000. He once served as the audit director and supervisor of the company. He is now the Secretary of the board of directors and the director of strategic investment of the company.
Up to now, Ms. Shi Wei holds 1318082 shares of the company. In addition, she is not related to other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
Ms. Zhang Wenjun, born in May 1990, Chinese nationality, without permanent residency abroad, has a master’s degree. He has worked in Maccura Biotechnology Co.Ltd(300463) since July 2016 and has obtained the qualification certificate of secretary of the board of directors issued by Shenzhen Stock Exchange. Currently, he is the securities affairs representative of the company.
Up to now, Ms. Zhang Wenjun has not directly or indirectly held the shares of the company, and has no relationship with other shareholders holding more than 5% of the shares of the company, and other directors, supervisors and senior managers of the company; There are no circumstances specified in Article 146 of the company law, and there are no circumstances specified in article 3.2.4 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – Guidelines for standardized operation of companies listed on GEM; There is no punishment by the CSRC and other relevant departments or the stock exchange; Not a dishonest person.
